CIK: 0001839948 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $609,794 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IVERIC BIO INC | 2,448,829 | $96,337 | 15.8% | $17.57 | — | COMM | 46583P102 |
| GERN | GERON CORP | 23,589,779 | $75,723 | 12.4% | $1.89 | +50.9% | COMM | 374163103 |
| COGT | COGENT BIOSCIENCES INC | 5,631,042 | $66,672 | 10.9% | $9.54 | +20.2% | COMM | 19240Q201 |
| — | VECTIVBIO HOLDING AG | 3,113,600 | $52,931 | 8.7% | $8.63 | — | COMM | H9060V101 |
| — | AEROVATE THERAPEUTICS INC | 2,201,274 | $37,752 | 6.2% | $15.75 | — | COMM | 008064107 |
| — | ICOSAVAC, INC | 3,703,704 | $36,778 | 6.0% | $9.93 | — | COMM | 45114M109 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 149,917 | $34,631 | 5.7% | $94.85 | +185.5% | COMM | 558868105 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $33,874 | 5.6% | $12.71 | +14.2% | COMM | 90240B106 |
| KALV | KALVISTA PHARMACEUTICALS, INC | 3,395,495 | $30,559 | 5.0% | $5.36 | +72.1% | COMM | 483497103 |
| VTYX | VENTYX BIOSCIENCES, INC | 815,724 | $26,756 | 4.4% | $29.94 | +15.1% | COMM | 92332V107 |
| DYN | DYNE THERAPEUTICS, INC | 1,650,150 | $18,564 | 3.0% | $12.99 | -9.2% | COMM | 26818M108 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $15,062 | 2.5% | $14.54 | -18.7% | COMM | 50127T109 |
| GPCR | STRUCTURE THERAPEUTICS INC | 350,000 | $14,550 | 2.4% | $23.79 | — | ADRS | 86366E106 |
| IMVT | IMMUNOVANT, INC | 654,853 | $12,423 | 2.0% | $12.59 | +48.1% | COMM | 45258J102 |
| SLN | SILENCE THERAPEUTICS PLC | 2,104,875 | $11,577 | 1.9% | $10.03 | — | ADRS | 82686Q101 |
| ANTX | AN2 Therapeutics, Inc. | 1,289,320 | $10,959 | 1.8% | $7.19 | 0.0% | COMM | 037326105 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $8,856 | 1.5% | $17.12 | — | COMM | 29384C108 |
| — | MERUS BV | 300,000 | $7,899 | 1.3% | $30.46 | — | COMM | N5749R100 |
| CABA | CABALETTA BIO, INC | 486,795 | $6,285 | 1.0% | $3.64 | +198.1% | COMM | 12674W109 |
| ACRS | ACLARIS THERAPEUTICS INC | 529,839 | $5,494 | 0.9% | $15.07 | -39.9% | COMM | 00461U105 |
| CCCC | C4 THERAPEUTICS, INC. | 1,276,574 | $3,511 | 0.6% | $5.83 | -44.9% | COMM | 12529R107 |
| — | ALPINE IMMUNE SCIENCES INC | 253,069 | $2,602 | 0.4% | $13.85 | — | COMM | 02083G100 |